Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News

MONARCH 2: Abemaciclib plus fulvestrant improves overall survival
- Author:
- Sharon Worcester
Publish date: October 1, 2019
News

PAOLA-1/ENGOT-ov25 trial: PARP inhibitor for maintenance improves PFS in advanced ovarian cancer
- Author:
- Sharon Worcester
Publish date: September 29, 2019
News

BAROCCO study: Cediranib-olaparib combination shows promise in PROC
- Author:
- Sharon Worcester
Publish date: September 28, 2019
News
German CLLM1 study: 4-year data raise concerns about lenalidomide maintenance
- Author:
- Sharon Worcester
Publish date: September 27, 2019
News

CheckMate 817: Nivo+ipi shows safety, efficacy across stage IV NSCLC subgroups
- Author:
- Sharon Worcester
Publish date: September 27, 2019
News
ICLL-07 trial: MRD-driven strategy yields prolonged survival
- Author:
- Sharon Worcester
Publish date: September 27, 2019
News
Cancer drug prices higher in U.S. than Europe; don’t correlate with clinical benefit
- Author:
- Sharon Worcester
Publish date: September 27, 2019
News

GALACTIC CLL trial: Obinutuzumab consolidation helps eradicate MRD
- Author:
- Sharon Worcester
Publish date: September 26, 2019
News

OS benefit with pembrolizumab endures long-term in advanced NSCLC
- Author:
- Sharon Worcester
Publish date: September 24, 2019
News
IMpower131: Improvement in OS for stage IV NSCLC+high-PD-L1 expression
- Author:
- Sharon Worcester
Publish date: September 13, 2019
News

Tissue TMB disappoints as treatment response biomarker in NSCLC
- Author:
- Sharon Worcester
Publish date: September 11, 2019
News

LDCT plus miRNA bolsters prevention efforts
- Author:
- Sharon Worcester
Publish date: September 9, 2019
News
MYSTIC trial analysis IDs mutations prognostic of mNSCLC outcomes
- Author:
- Sharon Worcester
Publish date: September 9, 2019
News

IASLC survey: Ongoing and intensified molecular testing education needed globally
- Author:
- Sharon Worcester
Publish date: September 8, 2019
News

New IASLC declaration targets tobacco use among cancer patients
- Author:
- Sharon Worcester
Publish date: September 8, 2019
